- Overview
TCS is here to make a difference through technology.
Leading the way in innovation for over 50 years, we build greater futures for businesses across multiple industries and 131 countries.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
Overview
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
- Overview
We’re in it for good, driving positive change for the benefit of all.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
-
About Us
-
Leadership
-
Events
- Overview
Extraordinary expertise leads to remarkable results.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
-
Customer Stories
-
Perspectives
-
Global studies
-
Topics
- Overview
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Overview
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
- Overview
Find the latest news about TCS in our Newsroom
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
-
Press releases
Recent Press releases
View all -
News alerts
-
Analyst recognition
Recent recognitions
View all -
Media kit
- Overview
TCS works hand in hand with world-leading investors.
Tata Consultancy Services LimitedNSE:TCSINR -
Management Commentary
-
Financials
-
News and Events
-
ESG
-
Resources
Overview
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
Top Results
Showing
10
01 - 07
You have these already downloaded
We have sent you a copy of the report to your email again.
For Roche, the COVID-19 scenario imposed an immediate threat having a detrimental impact on many of its ongoing and critical new clinical trials across different therapeutic areas. As a result, the team had to act fast to find a way to ensure business continuity of the impacted trials across all geographies. Read how Roche collaborated with TCS ADD team and implemented the TCS ADD Connected Clinical Trials (CCT)—eConsent solution to quickly rollout the digital informed consent.
About the author
Image of Dr. Hilde Vanaken
Dr. Hilde Vanaken
Dr Hilde is a passionate generalist with a track record of turning large & complex concepts into realization through collaboration. She joined TCS in 2019 as a Senior Industry Advisor for TCS Life Sciences & Healthcare having spent the previous +25 years at the pharma side where she shaped & led multiple cross-departmental & cross-pharma preclinical & clinical programs to success stories, e.g. Janssen’s Integrated Smart Trial & Engagement program, Transcelerate eConsent program.
Related reading
1/4
Life Sciences
Hilde Vanaken
Harmonization of eConsent The Key to Success
Article
|
31 Aug 2023
Opens in new tab
2/4
TCS ADD™
Alejandra Guerchicoff
Narayanan R
Tejas Almelkar
Transforming PV Efficiencies with ML and Rule-based Automation
White Paper
|
18 Aug 2023
Opens in new tab
3/4
TCS ADD™
Prasoon Sangwan
Digital Data Flow and Technological Solution Providers
Article
|
28 Jun 2023
Opens in new tab
4/4
TCS ADD™
Next-gen clinical trials on a digital platform
Customer Testimonial
|
27 Jan 2023
Opens in new tab
Transformation starts here
Learn how we can help you bring drugs to the market faster.
Talk to our expertsFind out more
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?